Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2026-01-24 @ 8:01 AM
Study NCT ID:
NCT03459534
Status:
RECRUITING
Last Update Posted:
2024-10-28
First Post:
2018-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs
Sponsor:
Organization: